Volpone John
SEC insider (Form 3/4/5 filer). CIK 0002081729. President at X4 Pharmaceuticals, Inc (XFOR). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in BOSTON, MA.
Companies Volpone John has filed insider reports for
- X4 Pharmaceuticals, Inc (XFOR): Officer, President
Volpone John
CIK: 0002081729
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
XFOR
X4 Pharmaceuticals, Inc
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 12, 2026XFOR
X4 Pharmaceuticals, Inc
SaleDirect24.6K shares at avg. $4.44$109K - Oct 29, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirectStock Option (right to buy)
2.3M shares- - Aug 14, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirect289.9K shares- - Aug 12, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirectStock Option (right to buy)
1.6M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | XFOR X4 Pharmaceuticals, Inc | Sale | 24,576 | $4.44 | $109,228 | Direct |
| Oct 29, 2025 | XFOR X4 Pharmaceuticals, Inc | Award Stock Option (right to buy) | 2,329,154 | - | - | Direct |
| Aug 14, 2025 | XFOR X4 Pharmaceuticals, Inc | Award | 289,881 | - | - | Direct |
| Aug 12, 2025 | XFOR X4 Pharmaceuticals, Inc | Award Stock Option (right to buy) | 1,609,873 | - | - | Direct |
1-4 of 4 transactions